Peripheral Nerve Stimulators Market Size, Share, Trends, & Industry Analysis Report By Product Type, By End User (Hospitals and Outpatient Centers), and By Region – Market Forecast, 2025–2034
Description
The peripheral nerve stimulators market size is expected to reach USD 971.25 Million by 2034, according to a new study by Polaris Market Research. The report “Peripheral Nerve Stimulators Market Share, Size, Trends, Industry Analysis Report: By Product Type, By End User (Hospitals and Outpatient Centers), and By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The peripheral nerve stimulators market provides solutions for managing chronic pain through implantable, percutaneous, and transcutaneous devices. These devices support applications in neuropathic pain, post-surgical pain, and musculoskeletal disorders to improve patient outcomes and reducing opioid dependency.
Market growth is driven by rising prevalence of chronic pain disorders, increasing healthcare expenditure, and adoption of minimally invasive neuromodulation therapies. Moreover, technological innovations in wireless and rechargeable medical devices are expanding clinical use and improving patient compliance.
Peripheral Nerve Stimulators Market Report Highlights
Based on product type, the implantable segment dominated in 2024, driven by long-term efficacy, high clinical adoption, and enhanced patient comfort.
In terms of end user, hospitals dominated in 2024, fueled by availability of advanced surgical infrastructure and specialized pain management centers.
North America dominated the global market in 2024, supported by advanced healthcare systems and favorable reimbursement policies.
Asia Pacific is projected to record the fastest growth, driven by increasing healthcare access and rising chronic pain cases.
Key players in the global market include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, B. Braun SE, Medline Industries, LP., Curonix LLC, SPR Therapeutics, Avanos Medical, Inc., Teleflex Incorporated, Curonix LLC, Xavant Technology, Vygon, and Neuspera Medical.
Polaris Market Research has segmented the market report based on product type, end user, and region:
By Product Type (Revenue, USD Million, 2020–2034)
Transcutaneous
Percutaneous
Implantable
By End User (Revenue, USD Million, 2020–2034)
Hospitals
Outpatient Centers
By Region (Revenue, USD Million, 2020–2034)
North America
The U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Netherland
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Australia
Rest of Asia Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Latin America
Saudi Arabia
UAE
South Africa
Israel
Rest of South Africa
The peripheral nerve stimulators market provides solutions for managing chronic pain through implantable, percutaneous, and transcutaneous devices. These devices support applications in neuropathic pain, post-surgical pain, and musculoskeletal disorders to improve patient outcomes and reducing opioid dependency.
Market growth is driven by rising prevalence of chronic pain disorders, increasing healthcare expenditure, and adoption of minimally invasive neuromodulation therapies. Moreover, technological innovations in wireless and rechargeable medical devices are expanding clinical use and improving patient compliance.
Peripheral Nerve Stimulators Market Report Highlights
Based on product type, the implantable segment dominated in 2024, driven by long-term efficacy, high clinical adoption, and enhanced patient comfort.
In terms of end user, hospitals dominated in 2024, fueled by availability of advanced surgical infrastructure and specialized pain management centers.
North America dominated the global market in 2024, supported by advanced healthcare systems and favorable reimbursement policies.
Asia Pacific is projected to record the fastest growth, driven by increasing healthcare access and rising chronic pain cases.
Key players in the global market include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, B. Braun SE, Medline Industries, LP., Curonix LLC, SPR Therapeutics, Avanos Medical, Inc., Teleflex Incorporated, Curonix LLC, Xavant Technology, Vygon, and Neuspera Medical.
Polaris Market Research has segmented the market report based on product type, end user, and region:
By Product Type (Revenue, USD Million, 2020–2034)
Transcutaneous
Percutaneous
Implantable
By End User (Revenue, USD Million, 2020–2034)
Hospitals
Outpatient Centers
By Region (Revenue, USD Million, 2020–2034)
North America
The U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Netherland
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Australia
Rest of Asia Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Latin America
Saudi Arabia
UAE
South Africa
Israel
Rest of South Africa
Table of Contents
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Peripheral Nerve Stimulators Market Insights
- 4.1. Peripheral Nerve Stimulators Market – Market Snapshot
- 4.2. Peripheral Nerve Stimulators Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Chronic Pain Disorders
- 4.2.1.2. Growing Healthcare Spending and Improved Access to Neurostimulation Treatments
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Implantation and Maintenance Costs
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Peripheral Nerve Stimulators Market Trends
- 4.6. Value Chain Analysis
- 5. Global Peripheral Nerve Stimulators Market, by Product Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 5.3. Transcutaneous
- 5.3.1. Global Peripheral Nerve Stimulators Market, by Transcutaneous, by Region, 2020-2034 (USD Million)
- 5.4. Percutaneous
- 5.4.1. Global Peripheral Nerve Stimulators Market, by Percutaneous, by Region, 2020-2034 (USD Million)
- 5.5. Implantable
- 5.5.1. Global Peripheral Nerve Stimulators Market, by Implantable, by Region, 2020-2034 (USD Million)
- 6. Global Peripheral Nerve Stimulators Market, by End User
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 6.3. Hospitals
- 6.3.1. Global Peripheral Nerve Stimulators Market, by Hospitals, by Region, 2020-2034 (USD Million)
- 6.4. Outpatient Centers
- 6.4.1. Global Peripheral Nerve Stimulators Market, by Outpatient Centers, by Region, 2020-2034 (USD Million)
- 7. Global Peripheral Nerve Stimulators Market, by Geography
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Peripheral Nerve Stimulators Market Assessment, By Geography, 2020-2034 (USD Million)
- 7.3. Peripheral Nerve Stimulators Market – North America
- 7.3.1. North America: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.3.2. North America: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.3.3. Peripheral Nerve Stimulators Market – U.S.
- 7.3.3.1. U.S.: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.3.3.2. U.S.: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.3.4. Peripheral Nerve Stimulators Market – Canada
- 7.3.4.1. Canada: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.3.4.2. Canada: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.4. Peripheral Nerve Stimulators Market – Europe
- 7.4.1. Europe: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.4.2. Europe: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.4.3. Peripheral Nerve Stimulators Market – UK
- 7.4.3.1. UK: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.4.3.2. UK: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.4.4. Peripheral Nerve Stimulators Market – France
- 7.4.4.1. France: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.4.4.2. France: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.4.5. Peripheral Nerve Stimulators Market – Germany
- 7.4.5.1. Germany: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.4.5.2. Germany: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.4.6. Peripheral Nerve Stimulators Market – Italy
- 7.4.6.1. Italy: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.4.6.2. Italy: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.4.7. Peripheral Nerve Stimulators Market – Spain
- 7.4.7.1. Spain: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.4.7.2. Spain: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.4.8. Peripheral Nerve Stimulators Market – Netherlands
- 7.4.8.1. Netherlands: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.4.8.2. Netherlands: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.4.9. Peripheral Nerve Stimulators Market – Russia
- 7.4.9.1. Russia: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.4.9.2. Russia: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.4.10. Peripheral Nerve Stimulators Market – Rest of Europe
- 7.4.10.1. Rest of Europe: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.4.10.2. Rest of Europe: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.5. Peripheral Nerve Stimulators Market – Asia Pacific
- 7.5.1. Asia Pacific: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.5.2. Asia Pacific: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.5.3. Peripheral Nerve Stimulators Market – China
- 7.5.3.1. China: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.5.3.2. China: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.5.4. Peripheral Nerve Stimulators Market – India
- 7.5.4.1. India: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.5.4.2. India: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.5.5. Peripheral Nerve Stimulators Market – Malaysia
- 7.5.5.1. Malaysia: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.5.5.2. Malaysia: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.5.6. Peripheral Nerve Stimulators Market – Japan
- 7.5.6.1. Japan: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.5.6.2. Japan: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.5.7. Peripheral Nerve Stimulators Market – Indonesia
- 7.5.7.1. Indonesia: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.5.7.2. Indonesia: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.5.8. Peripheral Nerve Stimulators Market – South Korea
- 7.5.8.1. South Korea: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.5.8.2. South Korea: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.5.9. Peripheral Nerve Stimulators Market – Australia
- 7.5.9.1. Australia: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.5.9.2. Australia: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.5.10. Peripheral Nerve Stimulators Market – Rest of Asia Pacific
- 7.5.10.1. Rest of Asia Pacific: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.5.10.2. Rest of Asia Pacific: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.6. Peripheral Nerve Stimulators Market – Middle East & Africa
- 7.6.1. Middle East & Africa: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.6.2. Middle East & Africa: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.6.3. Peripheral Nerve Stimulators Market – Saudi Arabia
- 7.6.3.1. Saudi Arabia: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.6.3.2. Saudi Arabia: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.6.4. Peripheral Nerve Stimulators Market – UAE
- 7.6.4.1. UAE: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.6.4.2. UAE: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.6.5. Peripheral Nerve Stimulators Market – Israel
- 7.6.5.1. Israel: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.6.5.2. Israel: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.6.6. Peripheral Nerve Stimulators Market – South Africa
- 7.6.6.1. South Africa: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.6.6.2. South Africa: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.6.7. Peripheral Nerve Stimulators Market – Rest of Middle East & Africa
- 7.6.7.1. Rest of Middle East & Africa: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.6.7.2. Rest of Middle East & Africa: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.7. Peripheral Nerve Stimulators Market – Latin America
- 7.7.1. Latin America: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.7.2. Latin America: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.7.3. Peripheral Nerve Stimulators Market – Mexico
- 7.7.3.1. Mexico: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.7.3.2. Mexico: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.7.4. Peripheral Nerve Stimulators Market – Brazil
- 7.7.4.1. Brazil: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.7.4.2. Brazil: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.7.5. Peripheral Nerve Stimulators Market – Argentina
- 7.7.5.1. Argentina: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.7.5.2. Argentina: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 7.7.6. Peripheral Nerve Stimulators Market – Rest of Latin America
- 7.7.6.1. Rest of Latin America: Peripheral Nerve Stimulators Market, by Product Type, 2020-2034 (USD Million)
- 7.7.6.2. Rest of Latin America: Peripheral Nerve Stimulators Market, by End User, 2020-2034 (USD Million)
- 8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
- 9. Company Profiles
- 9.1. Abbott Laboratories
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Type Benchmarking
- 9.1.4. Recent Development
- 9.2. Avanos Medical, Inc.
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Type Benchmarking
- 9.2.4. Recent Development
- 9.3. Boston Scientific Corporation
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Type Benchmarking
- 9.3.4. Recent Development
- 9.4. B. Braun SE
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Type Benchmarking
- 9.4.4. Recent Development
- 9.5. Curonix LLC
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Type Benchmarking
- 9.5.4. Recent Development
- 9.6. Medline Industries, LP.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Type Benchmarking
- 9.6.4. Recent Development
- 9.7. Medtronic plc
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Type Benchmarking
- 9.7.4. Recent Development
- 9.8. Neuspera Medical
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Type Benchmarking
- 9.8.4. Recent Development
- 9.9. SPR Therapeutics
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Type Benchmarking
- 9.9.4. Recent Development
- 9.10. Teleflex Incorporated
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Type Benchmarking
- 9.10.4. Recent Development
- 9.11. Vygon
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Type Benchmarking
- 9.11.4. Recent Development
- 9.12. Xavant Technology
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Type Benchmarking
- 9.12.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
